Document is current
Any future updates will be listed below
-
Authors
Zhang, Yuyu
Tang, Nailong
Lei, Lei
Lv, Runxin
Zhang, Yaochi
Liu, Nian
Chen, Haixia
Cai, Min
Wang, Huaning
-
Funding
Funding for this research was provided by:
Key Programme (82330043)
- License Information
-
More Information
Article History
Received: 12 November 2023
Accepted: 9 February 2024
First Online: 21 February 2024
Declarations
:
: This trial has been approved by the Ethical Committee of Xijing Hospital, Xian, China (approved number: XJLL-KY20222175), and is registered with the ClinicalTrials.gov database (NCT05555940). Any modification of the study protocol will be submitted to the Ethics Committee of Xijing Hospital. Before all patients are enrolled in the study, we will fully explain the purpose of the study, the process of the study, and the risks and benefits of the study. The patients will sign the informed consent form after understanding. Patients participating in this study were completely voluntary and had the right to withdraw at any time.
: The participant information materials and informed consent form are available from the corresponding author on request. Informed consent materials are attached as InternalRef removed.
: The authors declare that they have no competing interests.
